A detailed history of Ellenbecker Investment Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Ellenbecker Investment Group holds 262 shares of LLY stock, worth $195,504. This represents 0.04% of its overall portfolio holdings.

Number of Shares
262
Previous 432 39.35%
Holding current value
$195,504
Previous $391,000 40.66%
% of portfolio
0.04%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$772.14 - $960.02 $131,263 - $163,203
-170 Reduced 39.35%
262 $232,000
Q2 2024

Jul 11, 2024

BUY
$724.87 - $909.04 $102,931 - $129,083
142 Added 48.97%
432 $391,000
Q1 2024

Apr 09, 2024

BUY
$592.2 - $792.28 $171,738 - $229,761
290 New
290 $225,000
Q3 2023

Oct 17, 2023

BUY
$434.7 - $599.3 $187,355 - $258,298
431 New
431 $231,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ellenbecker Investment Group Portfolio

Follow Ellenbecker Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellenbecker Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Ellenbecker Investment Group with notifications on news.